Diversity of quasispecies in various disease stages of chronic hepatitis C virus infection and its significance in interferon treatment - PubMed (original) (raw)

Affiliations

PMID: 7541387

Diversity of quasispecies in various disease stages of chronic hepatitis C virus infection and its significance in interferon treatment

K Koizumi et al. Hepatology. 1995 Jul.

Abstract

Hepatitis C virus (HCV) populations in vivo exist as a mixture of heterogeneous viruses called quasispecies, which have variations in the hypervariable region (HRV). However, the relationship between the diversity of HVR quasispecies, the disease stage, or the interferon (IFN) responsiveness remains to be elucidated. To study these, serum samples were obtained from 42 patients with chronic hepatitis C virus infection; 24 with chronic active hepatitis (CAH) treated with IFN, 9 with cirrhosis, 9 with hepatocellular carcinoma (HCC). HCV quasispecies populations were separated by the single-strand conformation polymorphism (SSCP) method targeted to the HVR. The patients were classified into two groups; a single-band group (n = 12) in which HVR quasispecies was homogeneous and a multiple-band group (n = 30) in which HVR quasispecies was heterogeneous. Patients with multiple bands had significantly more advanced liver disease than those with a single-band group (P = .0082). The percentage of patients with single band were 41% in CAH, 22% in cirrhosis, and 0% in HCC. Multivariate analyses showed that viral diversity was independently related to the progression of liver disease and was not correlated with the duration of infection. We also found that in CAH, the patients who had multiple bands (n = 14) were more resistant to IFN therapy than those who had a single band (n = 10) (P = .002). These results indicate that the diversity of HCV quasispecies becomes more complex as the disease stage progresses and that CAH with more complex diversity shows less IFN effectiveness.

PubMed Disclaimer

Cited by

Puzzles, challenges, and information reservoir of SARS-CoV-2 quasispecies.
Domingo E, Martínez-González B, García-Crespo C, Somovilla P, de Ávila AI, Soria ME, Durán-Pastor A, Perales C. Domingo E, et al. J Virol. 2023 Dec 21;97(12):e0151123. doi: 10.1128/jvi.01511-23. Epub 2023 Nov 21. J Virol. 2023. PMID: 38092661 Free PMC article. Review.
The dynamic changes of HBV quasispecies diversity in infancy after immunoprophylaxis failure: a prospective cohort study.
Li Y, Xiao Y, Li L, Song Y, Zhai X, Liu J, Duan Z, Yan L, Ding F, Liu J, Zhu L, Jiang J, Zou H, Li L, Liang C, Wang J, Li J. Li Y, et al. Virol J. 2021 Nov 29;18(1):236. doi: 10.1186/s12985-021-01707-9. Virol J. 2021. PMID: 34844612 Free PMC article.
Comparison of quasispecies diversity of HCV between chronic hepatitis c and hepatocellular carcinoma by Ultradeep pyrosequencing.
Park CW, Cho MC, Hwang K, Ko SY, Oh HB, Lee HC. Park CW, et al. Biomed Res Int. 2014;2014:853076. doi: 10.1155/2014/853076. Epub 2014 Jun 5. Biomed Res Int. 2014. PMID: 24999482 Free PMC article.
High diversity of hepatitis C viral quasispecies is associated with early virological response in patients undergoing antiviral therapy.
Fan X, Mao Q, Zhou D, Lu Y, Xing J, Xu Y, Ray SC, Di Bisceglie AM. Fan X, et al. Hepatology. 2009 Dec;50(6):1765-72. doi: 10.1002/hep.23290. Hepatology. 2009. PMID: 19937690 Free PMC article.
The quasispecies nature and biological implications of the hepatitis C virus.
Fishman SL, Branch AD. Fishman SL, et al. Infect Genet Evol. 2009 Dec;9(6):1158-67. doi: 10.1016/j.meegid.2009.07.011. Epub 2009 Aug 8. Infect Genet Evol. 2009. PMID: 19666142 Free PMC article. Review.

Diversity of quasispecies in various disease stages of chronic hepatitis C virus infection and its significance in interferon treatment - PubMed (original) (raw)